Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP521032.RAVvx7k3w1F4c76cjXCAjlV9XIthiUlI5ykEI2ntxFDoM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP521032.RAVvx7k3w1F4c76cjXCAjlV9XIthiUlI5ykEI2ntxFDoM130_assertion type Assertion NP521032.RAVvx7k3w1F4c76cjXCAjlV9XIthiUlI5ykEI2ntxFDoM130_head.
- NP521032.RAVvx7k3w1F4c76cjXCAjlV9XIthiUlI5ykEI2ntxFDoM130_assertion description "[Association with other oncogene expression (TAL1, HOXAs, or TLX3/HOX11L2), NOTCH1 activating mutations, and/or CDKN2A/p16/ARF deletion, showed that cyclin D2 dysregulation could contribute to multi-event oncogenesis in various T-ALL groups.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP521032.RAVvx7k3w1F4c76cjXCAjlV9XIthiUlI5ykEI2ntxFDoM130_provenance.
- NP521032.RAVvx7k3w1F4c76cjXCAjlV9XIthiUlI5ykEI2ntxFDoM130_assertion evidence source_evidence_literature NP521032.RAVvx7k3w1F4c76cjXCAjlV9XIthiUlI5ykEI2ntxFDoM130_provenance.
- NP521032.RAVvx7k3w1F4c76cjXCAjlV9XIthiUlI5ykEI2ntxFDoM130_assertion SIO_000772 16270038 NP521032.RAVvx7k3w1F4c76cjXCAjlV9XIthiUlI5ykEI2ntxFDoM130_provenance.
- NP521032.RAVvx7k3w1F4c76cjXCAjlV9XIthiUlI5ykEI2ntxFDoM130_assertion wasDerivedFrom befree-2016 NP521032.RAVvx7k3w1F4c76cjXCAjlV9XIthiUlI5ykEI2ntxFDoM130_provenance.
- NP521032.RAVvx7k3w1F4c76cjXCAjlV9XIthiUlI5ykEI2ntxFDoM130_assertion wasGeneratedBy ECO_0000203 NP521032.RAVvx7k3w1F4c76cjXCAjlV9XIthiUlI5ykEI2ntxFDoM130_provenance.